Literature DB >> 6452055

Altered cellular immune functions in patients with Down's syndrome.

C A Spina, D Smith, E Korn, J L Fahey, H J Grossman.   

Abstract

Cell-associated immunocompetence was evaluated in 42 patients with Down's syndrome (DS) and compared with that of institutionalized patient control and normal control groups. B lymphocytes, as both percent of total lymphoid cells and absolute number, were markedly reduced in patients with DS. T-lymphocyte proliferative response to phytohemagglutinin mitogen also was significantly decreased. This altered response of the lymphocyte population was evident in both the presence and absence of accessory helper monocytes. Increased Fc receptor (FcR) cell activity, as measured by antibody-dependent cellular cytotoxicity was seen in both the patients with DS and the control patients. This probably resulted from common environmental factors such as exposure to infectious factors such as exposure to infectious agents. No change was found in the WBC counts, percentages of lymphocytes and monocytes, percentages of t cells and FcR cells, or in the natural killer cell activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6452055     DOI: 10.1001/archpedi.1981.02130270043015

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  8 in total

1.  Serum levels of gamma interferon in patients with Down's syndrome.

Authors:  D Torre; M Broggini; C Zeroli; L Agrifoglio; V Bottà; R Casalone; G Ferrario
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

2.  Comparison of the care of children with Down's syndrome with the care of matched controls.

Authors:  J C Murdoch
Journal:  J R Coll Gen Pract       Date:  1984-04

Review 3.  Malignancy in children with trisomy 21.

Authors:  Karen R Rabin; James A Whitlock
Journal:  Oncologist       Date:  2009-01-28

4.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

Review 5.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

6.  COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course.

Authors:  Ahmad Kantar; Angelo Mazza; Ezio Bonanomi; Marta Odoni; Manuela Seminara; Ilaria Dalla Verde; Camillo Lovati; Stefania Bolognini; Lorenzo D'Antiga
Journal:  BMC Pediatr       Date:  2020-12-18       Impact factor: 2.125

7.  The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.

Authors:  C A Spina; T J Kwoh; M Y Chowers; J C Guatelli; D D Richman
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

Review 8.  Down Syndrome and COVID-19: A Perfect Storm?

Authors:  Joaquin M Espinosa
Journal:  Cell Rep Med       Date:  2020-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.